Weiss GJ, Blaydorn L, Beck J, Bornemann-Kolatzki K, Urnovitz H, Sch?tz E, Khemka V. Correction to: Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma. Invest New Drugs. 2019 Aug; 37(4):797.